These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 24903556)

  • 21. Efficacy and safety of bicyclol for treating patients with antituberculosis drug-induced liver injury.
    Du Y; Gu J; Yang Y; Chen Y; Wang Y; Mei Z; Li Y; Li L; Xue D; Wang X; Li D; Hu P; Nie W; Chu N
    Int J Tuberc Lung Dis; 2024 Jan; 28(1):6-12. PubMed ID: 38178298
    [No Abstract]   [Full Text] [Related]  

  • 22. Semimechanistic pharmacokinetic/pharmacodynamic model for hepatoprotective effect of dexamethasone on transient transaminitis after trabectedin (ET-743) treatment.
    Fetterly GJ; Owen JS; Stuyckens K; Passarell JA; Zannikos P; Soto-Matos A; Izquierdo MA; Perez-Ruixo JJ
    Cancer Chemother Pharmacol; 2008 Jun; 62(1):135-47. PubMed ID: 17922277
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of bicyclol on immunological liver fibrosis in rats.
    Gu Y; Zhao J; Yao XM; Li Y
    J Asian Nat Prod Res; 2010 May; 12(5):388-98. PubMed ID: 20496196
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Resolution of racemic anti-hepatitis drug ( +/- ) -bicyclol].
    Hu W; Zhang CZ; Li Y
    Yao Xue Xue Bao; 2006 Mar; 41(3):221-4. PubMed ID: 16758991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Protective effect of bicyclol on concanavalin A-induced liver nuclear DNA injury in mice].
    Zhao D; Liu G
    Zhonghua Yi Xue Za Zhi; 2001 Jul; 81(14):844-8. PubMed ID: 11702677
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidence of liver injury among cancer patients receiving chemotherapy in an integrated health system.
    Ulcickas Yood M; Bortolini M; Casso D; Beck JG; Oliveria SA; Wells KE; Woodcroft KJ; Wang LI
    Pharmacoepidemiol Drug Saf; 2015 Apr; 24(4):427-34. PubMed ID: 25683797
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protective effect of bicyclol against bile duct ligation-induced hepatic fibrosis in rats.
    Zhen YZ; Li NR; He HW; Zhao SS; Zhang GL; Hao XF; Shao RG
    World J Gastroenterol; 2015 Jun; 21(23):7155-64. PubMed ID: 26109801
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic potential of bicyclol in liver diseases: Lessons from a synthetic drug based on herbal derivative in traditional Chinese medicine.
    Zhao T; Mao L; Yu Z; Hui Y; Feng H; Wang X; Lin L; Fan X; Chen X; Wang B; Cao X; Sun C
    Int Immunopharmacol; 2021 Feb; 91():107308. PubMed ID: 33383448
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protective effect of Danning tablet on acute livery injury with cholestasis induced by α-naphthylisothiocyanate in rats.
    Ding LL; Zhang BF; Dou W; Yang L; Zhan CS; Wang ZT
    J Ethnopharmacol; 2012 Mar; 140(2):222-9. PubMed ID: 22274634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A single-center, prospective and randomized controlled study: Can the prophylactic use of lamivudine prevent hepatitis B virus reactivation in hepatitis B s-antigen seropositive breast cancer patients during chemotherapy?
    Long M; Jia W; Li S; Jin L; Wu J; Rao N; Feng H; Chen K; Deng H; Liu F; Su F; Song E
    Breast Cancer Res Treat; 2011 Jun; 127(3):705-12. PubMed ID: 21445574
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of bicyclol on gene expression profiles in mice with liver injury induced by concanavalin A].
    Yu YN; Guo J; Li Y; Hong Y; Li K; Cheng J; Li Y
    Yao Xue Xue Bao; 2008 Jun; 43(6):596-600. PubMed ID: 18822961
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Silybum marianum (milk thistle) in the management and prevention of hepatotoxicity in a patient undergoing reinduction therapy for acute myelogenous leukemia.
    McBride A; Augustin KM; Nobbe J; Westervelt P
    J Oncol Pharm Pract; 2012 Sep; 18(3):360-5. PubMed ID: 22378810
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Liver damage in hormone therapy of prostate cancer].
    Zade W; Schott H
    Z Urol Nephrol; 1987 Mar; 80(3):177-9. PubMed ID: 3604474
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A preliminary study of apparent diffusion coefficient in chemotherapy-induced liver damage.
    Zhang Q; Yu NN; Wen LJ; Liu GL; Tang J; Yuan ZG; Liu ZQ
    Eur J Radiol; 2012 Nov; 81(11):2943-6. PubMed ID: 22260894
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Scutellarin protects against the liver injury induced by diosbulbin B in mice and its mechanism.
    Niu C; Sheng Y; Yang R; Lu B; Bai Q; Ji L; Wang Z
    J Ethnopharmacol; 2015 Apr; 164():301-8. PubMed ID: 25701748
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dietary glycine protects from chemotherapy-induced hepatotoxicity.
    Mikalauskas S; Mikalauskiene L; Bruns H; Nickkholgh A; Hoffmann K; Longerich T; Strupas K; Büchler MW; Schemmer P
    Amino Acids; 2011 Apr; 40(4):1139-50. PubMed ID: 20852907
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of a HER2 tyrosine kinase inhibitor CP-724,714 in patients with advanced malignant HER2 positive solid tumors: correlations with clinical characteristics and safety.
    Guo F; Letrent SP; Munster PN; Britten CD; Gelmon K; Tolcher AW; Sharma A
    Cancer Chemother Pharmacol; 2008 Jun; 62(1):97-109. PubMed ID: 17805538
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatotoxicity of chemotherapeutic agents.
    Perry MC
    Semin Oncol; 1982 Mar; 9(1):65-74. PubMed ID: 7071610
    [No Abstract]   [Full Text] [Related]  

  • 39. Hepatotoxicity of chemotherapy.
    King PD; Perry MC
    Oncologist; 2001; 6(2):162-76. PubMed ID: 11306728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liver function tests profile in cancer patients on cytotoxic chemotherapy: a preliminary report.
    Akuyam SA; Uchenna OK; Adamu A; Aliyu IS; Mai A; Dawotola DA; Adewuyi SA
    Niger Postgrad Med J; 2011 Mar; 18(1):34-3. PubMed ID: 21445111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.